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Walking on irregular terrain influences gait of diabetic patients.We investigate the test-retest reliability and construct validity of gait
measured with the DynaPort MiniMod under single and dual task conditions in diabetic patients walking on irregular terrain to
identify the measurement error (precision) andminimal clinical detectable change. 29 patients with Type 2 diabetes were measured
once, and 25 repeated the measurement within 7 days. Patients walked on a therapy garden walkway. Diﬀerences between three
groups of diabetics with various levels of lower extremity neuropathy were analyzed with planned contrasts. ICC was excellent for
intervisit measurements with ICC’s > 0.824. Bland and Altman Plots, SEM, and SDD showed precise values, distributed around
zero for both test conditions. A significant eﬀect of grouping on step length performance hints at possible construct validity of the
device. Good reliability of DynaPort MiniMod measurements on a therapy garden walkway and an indication for discriminatory
capability suggests that DynaPort MiniMod could facilitate the study of gait in diabetic patients in conditions close to real-life
situations. Good reliability, small measurement error, and values of minimal clinical detectable change recommend the further
utilization of DynaPort MiniMod for the evaluation of gait parameters in diabetic patients.
1. Introduction
TheWorldHealthOrganization has described type 2 diabetes
as an international epidemic. Current estimates suggest that
the number of persons with diabetes will reach 300million by
2025 [1]. Fifty percent of patients who have diabetes for more
than 20 years develop peripheral neuropathy (PN), which
aﬀects nerve function from the periphery to more proximal
regions [2, 3]. Because the increasing prevalence of diabetes
is accompanied by gait problems and a heightened risk of
falling, there is an increased need for understanding the
possible gait pattern changes diabetic patients are confronted
with [4]. It has, furthermore, been demonstrated that
patients with diabetes may also improve their gait due to
specific exercise programs [5, 6].
In this context gait analysis is usually performed in
specialized kinesiology laboratories. Cameras, force plat-
forms, and magnetic and ultrasound systems are thereby
often used technologies for the gait analysis [7, 8]. However,
time expenditure and financial constraints limit their use in
clinical practice [9]. Moreover, gait analyses are traditionally
performed indoors, on a predefined, clean, and flat specific
pathway. Such conditions enable precise recording but are
not representative of the real-life context. Activities of daily
life require us to move about in challenging environments
and to walk on varied surfaces. Irregular terrain has been
shown to influence gait parameters such as speed, especially
in a population at risk for falling [10], for example,
patients with Diabetes [11, 12]. Furthermore, the fact that
falling mainly occurs in a complex environment [13] under
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attention demanding conditions emphasizes the need for
clinicians to objectively record gait data in a real-life context
[14] under dual task conditions [15].
The recent use of body-fixed sensors suggests that they
could serve as a tool for analyzing the gait of patients
in more challenging walking environments [16–18]. In
comparison with other motion measurement devices, body-
fixed sensors have the advantage of being lightweight and
portable, which enables subjects to move relatively freely.
They permit data collection in a challenging environment;
they are easy to use, provide a good ratio in terms of cost
and amount of information retrieved, and can capture data
from many gait cycles. Thus they seem ideal for extending
our understanding of gait changes in specific populations
by performing measures in real-life conditions, for example,
in diabetic patients [19]. An objective evaluation in real-
life conditions might help understand the causes of diabetic
gait problems and ultimately facilitate the choice or the
development of appropriate physical treatment. Therefore,
the potential of body-fixed sensor approaches should be
investigated in the diabetic population in order to ensure
the validity and the reliability of data recorded during gait
analysis under single and dual task conditions on changing
types of surfaces.
To be clinically useful, an assessment procedure must
have a small measurement error to detect a real change
and must be able to distinguish between subpopulations for
example, diabetic patients with and without various stages
of peripheral neuropathy. A test-retest diﬀerence in a patient
with a value smaller than the standard error of the measure-
ment (SEM) is likely to be the result of “measurement noise”
and is unlikely to be detected reliably in practice; a diﬀerence
greater than the smallest real diﬀerence is highly likely
(with 95% confidence) to be a real diﬀerence [20]. Another
example of these statistics is the smallest detectable diﬀerence
(SDD) [21]. The DynaPort MiniMod body-fixed sensor has
previously been shown to be reliable, valid, and valuable
in elderly for the analysis of gait performed on challenging
surfaces [22–25]. To date, little is known about the variability
in gait measures within the diabetic population and the
reliable use of accelerometers in these patients. With this
in mind, we conducted this study to (a) investigate the
validity and reliability of gait parameters measured with
DynaPort MiniMod in diabetic patients walking under
single and dual task conditions on a challenging walking
course, (b) identify the measurement error (precision),
and (c) identify the smallest clinical detectable diﬀerence.
We hypothesized [1] that walking quality in patients with
diabetes can be reliably measured with accelerometers [2],
that the walking quality is diﬀerent in patient subgroups (we
expect diabetic neuropathy to change gait quality compared
to the group with no neuropathy), and [3] we believe that
severe neuropathy eﬀects walking quality more than mild
neuropathy.
2. Methods
The study was approved by the ethics committee in
Canton Zurich. All participants received written and oral
information and were requested to sign an informed consent
statement.
2.1. Subjects. A convenience sample of 31 patients with
diabetes Type 2 (with and without neuropathy) was recruited
from the patients consulting the Division of Endocrinology,
Diabetes and Clinical Nutrition, University Hospital of
Zurich (Table 1). Patients were included if they were medi-
cally diagnosed with diabetes Type 2, were between 50 and
70 years of age, and had the ability to walk without assistive
devices. Patients were excluded if they had concomitant
foot ulcer, orthopaedic or surgical problems influencing
gait parameters, a nondiabetic neuropathy (due to Charcot-
Marie-Tooth disease, alcohol, or thyroid dysfunction), or
neurological pathology influencing gait parameters.
Before gait analysis started, patients were assigned to one
of three groups: “DIABETIC,” “MILD NEUROPATHY,” and
“SEVERE NEUROPATHY” based on three tests. A Neurom-
eter CPT electrodiagnostic device was used for sensory nerve
conduction threshold (sNCT) evaluations at the great toe by
determining current perception threshold (CPT) levels. CPT
permits diagnosis of neuropathy due to its ability to diagnose
and quantify hyperaesthesia [26]. The used Rapid Screening
CPT (R-CPT) resulted in a value between 1 and 25, where
the higher numbers indicate worse nerve conduction. The
value was used to grade neuropathy: no neuropathy = 6–
13, moderate neuropathy = 14–19, severe neuropathy = 20–
25. The Rydel-Seiﬀer tuning fork test was used to assess the
vibratory threshold perception at the base of the great toe
as a good predictor for impairment of the vibratory senses
and, therefore, also usable to diagnose neuropathy [27–29].
The Rydel-Seiﬀer tuning fork test acquires values between
0 and 8, where the higher values indicate better vibratory
senses. Patients were grouped by the test in one of the three
categories with application of an age-related correction [30].
The third test used was the Semmes-Weinsteinmonofilament
test, a good test to diagnose but not to quantify neuropathy
[31]. If the subjects did not notice five of seven stimuli, a
neuropathy was diagnosed.
Testing and group assignment was performed by an MD
unfamiliar with the study design and the patients. Based on
the results of all three tests the MD categorized the patients
in one of three categories. TheMD principally considered the
results from the Neurometer CPT/C tests where three values
for every frequency were obtained for the right and the left
great toe. If at least two frequencies of the worse foot had
a value over 14, the subject was allocated to the “moderate
neuropathy’’ group. If at least two frequencies of the worse
foot had a value over 19, the subject was allocated to the
“severe neuropathy” group. If there were any uncertainties in
the group allocation according to R-CPT values, the Rydel-
Seiﬀer tuning fork test was the next criteria considered. The
loading of the group arrangement’s criteria was Neurometer
CPT/C > Rydel-Seiﬀer tuning fork > Semmes-Weinstein
monofilament test.
After the analysis of nerve conduction the gait analysis
started.
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Table 1: Demographic description of the consecutively recruited subjects at baseline.
Subject (no.) Sex (m/f) Age (years) Weight (kg) Height (m) BMI (kg/m2) Group∗
01 m 60 82 1.76 26.5 2
02 m 70 88 1.74 29.1 2
03 f 64 92 1.73 30.7 3
04 m 63 94 1.76 30.4 3
05 m 69 84 1.76 27.1 2
06 m 57 102 1.78 32.2 2
07 f 63 67 1.55 27.9 2
08 m 70 95 1.76 30.7 3
09 m 69 73 1.79 22.8 2
10 m 57 98 1.84 29 3
11 m 61 103 1.79 32.2 1
12 m 69 66 1.72 22.3 2
13 m 53 90 1.71 30.8 3
14 m 70 102 1.85 29.8 3
15 f 67 78 1.64 29 1
16 m 65 94 1.74 31.1 1
17 m 62 81 1.75 26.5 1
18 m 62 92 1.70 31.8 1
19 m 56 108 1.82 32.6 1
20 m 59 67 1.67 24 1
21 m 60 76 1.73 25.4 1
22 m 56 93 1.70 32.2 1
23 f 64 54 1.60 21.1 2
24 m 60 92 1.78 29.0 1
25 f 50 60 1.63 22.6 2
26 m 57 85 1.80 26.2 2
27 f 60 75 1.60 29.3 1
28 m 55 85 1.78 26.8 1
29 m 65 81 1.87 23.2 2
BMI: body mass index; ∗1: “diabetic,” 2: “mild neuropathy,” and 3: “severe neuropathy”; m/f: male/female.
2.2. Apparatus. A triaxial accelerometer (DynaPort Mini-
Mod, McRoberts BV, The Hague, The Netherlands) was
used to measure pelvic accelerations. The accelerometer was
placed at the lower back of the subject with the center of the
device at the level of the second sacral vertebrae.
2.3. Test Procedures. Each subject was assessed during usual
walking at preferred velocity under two diﬀerent conditions
over an outdoor gait therapy walkway with diﬀerent surfaces:
(1) silent walking on the walkway and (2) walking on
the walkway with a counting task. The walkway con-
tained a paved trajectory, cobble stones, and gravel rocks
(Figure 1(a)). The complete walkway was 31meter long
and 1.5meter wide. To measure steady state- walking, the
16.6meters (with the three diﬀerent surfaces) of the walking
course was used as the test distance. The remaining parts of
the walkway were used for acceleration and deceleration. At
the end of the first 31 meters the subjects had to stop for two
seconds, then turn around, and walk the walkway back to the
starting point. At the beginning themeasurement was started
(S), and, at the end, the measurement was stopped (S + M5;
Figure 1(b)).
(1) Test run with subject’s preferred walking speed: the
subject received the most important information: no
speaking, hold arms out of the pocket, and try not to
stop walking during the measurement.
(2) First trial with preferred walking speed: the subject
was briefed to “walk like you would bring a letter to
the mailbox” (single task).
(3) Second trial with preferred walking speed and an
additional cognitive task (count backwards aloud in
steps of three): the subject had to walk and count
aloud in steps of three. The subject was briefed to
“try to walk and count at the same time. Do not
favour one task over the other but try to perform these
concurrently” (dual task).
The dual task was subtracting repeatedly the number
three starting from 200 down and was practiced before gait
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Figure 1: (a) The gait garden walkway with paved trajectory, cobble stones, and gravel rocks. (b) Schematic representation of the walkway
and test procedure used. M signifies markers that are set in the signal to recognize the gait data for analyses.
testing while sitting on a chair. Subjects were told to try and
perform both tasks at the same time without prioritizing
either the walking or counting. A small receiver was mounted
on the accelerometer and the researcher placed a marker in
the data through triggering by the use of a remote control
when the subjects passed distance lines (Figure 1(b)). The
researcher walked alongside the subjects to ensure their
safety. At the end of the last trial the SD card was removed
from the accelerometer, and the measurements were checked
for completeness on a laptop. The subject was asked to come
again for the retest one week later at the same time and to
wear the same shoes as during the first trial.
Per trial, all measured data between the two trigger
signals (M1-M2/M3-M4) were used for analysis. Walking
speed (V), cadence, mean values (X) of step duration (SDu)
and step length (SL), and corresponding standard deviations
(SD) were calculated for each subject and each trial.
3. Statistical Analyses
Normality of the data was tested with the Kolmogorov-
Smirnov test. Descriptive statistics were used to define the
study population and to calculate gait characteristics.
We used the intraclass correlation (ICC(2,1)) with 95%
confidence intervals to calculate intervisit reliability between
visit 1 and visit 2. ICC(2,1) was used because individual
ratings constitute the unit of analysis, and raters and subjects
were conceived as being a random selection. There was one
week between visit 1 and 2. To interpret ICC(2,1) values
we used benchmarks suggested by Shrout and Fleiss [32]
(>0.75 excellent reliability, 0.4–0.75 fair to good reliability,
and <0.4 poor reliability). To evaluate precision the 95%
limits of agreement statistics (Bland and Altman) were used.
It expresses the degree of error proportional to the mean,
and was calculated as d ± 2SDdiﬀ [33, 34], where d is
the mean of the diﬀerence and SDdiﬀ the standard deviation
of the diﬀerence. The measurement error (standard error
of the mean diﬀerence (SEM)) was reported, and the
smallest detectable diﬀerence (SDD) for each parameter was
calculated as described by de Vet et al. [35]. SEM was derived
by σ
√
(1− ICC) in which σ represents the total variance
[36]. The smallest detectable change was calculated with the
formula 1.96× SEM×√2.
To identify diﬀerences between groups we used an
analysis with planned contrasts [37]. All statistical analyses
were performed using SPSS 17 for Windows (SPSS Inc.).
4. Results
Of the 31 patients screened for eligibility all met the inclusion
criteria. Data from two individuals were, however, not
available. One person presented with hypersensibility of
the feet and could not be measured. Technical problems
prevented data acquisition for the second person. This
resulted in complete data for 29 patients (21 male and
8 female) at baseline, mean age: 61.9 (±5.5) years; body
mass index: 28.2 (±3.5)) kg/m2; leg length 0.84 (±0.06) m
(Table 1).
Twelve patients were categorized as “DIABETIC,” eleven
as “MILD NEUROPATHY,” and six as “SEVERE NEUROPA-
THY.” Post hoc ANOVA revealed that the groups did not
diﬀer in Age F(2, 26) = 0.949, P = .40; height F(2, 26) =
1.26, P = .302; SDu F(2, 26) = 1.99, P = .157; V F(2, 26) =
3.01, P = .067; cadence F(2, 26) = 1.98, P = .159 and showed
to be diﬀerent for weight F(2, 26) = 4.729, P = .018; BMI
F(2, 26) = 4.28, P = .025; SL F(2, 26) = 3.14, P = .048.
Four patients were unable or refused to perform the
retest due to time limitations or lack of motivation. For
the reliability testing we had twenty-five patients performing
retesting (17 male and 8 female); mean age: 61 (±5.7)
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Table 2: Results of repeated measurements (N = 25).
Test visit 1
mean ± SD
Test visit 2
mean ± SD P value
Single task
SDu (s) 0.54 (0.051) 0.55 (0.045) 0.771
SL (m) 0.69 (0.095) 0.69 (0.111) 0.884
V (m/s) 1.28 (0.213) 1.28 (0.243) 0.942
Cad (step/min) 111.7 (10.234) 111.0 (9.031) 0.652
Dual task
SDu (s) 0.58 (0.079) 0.56 (0.056) 0.046
SL (m) 0.67 (0.109) 0.68 (0.107) 0.325
V (m/s) 1.17 (0.273) 1.23 (0.233) 0.154
Cad (step/min) 104.51 (12.626) 107.7 (10.170) 0.046
SD: standard deviation; SDu: step duration; SL: step length;V : velocity; Cad:
cadence.
years; Body Mass Index: 28.7 (±3.5) kg/m2, leg length 0.83
(±0.06) m. Eleven patients were “DIABETIC,” eight “MILD
NEUROPATHY” and six “SEVERE NEUROPATHY”.
4.1. Diﬀerences between the Walking Conditions. Table 2
presents means and SDs of both tests. Significant diﬀerences
between the two test conditions at baseline, single versus dual
task walking, were identified for all gait parameters (walking
speed: t(28) = 3.616, P = .001, cadence: t(28) = 3.221,
P = .003, step duration: t(28) = −3.112, P = .004, and step
length: t(28) = 2.308, P = .029. Walking speed, step length,
and cadence were significantly decreased under dual tasking,
and step duration was significantly increased compared to
normal walking.
4.2. Reliability. All data were normally distributed and
showed no heteroscedasticity. The results of the repeated
measurements for the diﬀerent gait parameters SDu, SL, V,
and Cadence are presented in Table 2. Except for cadence
under dual task condition there were no diﬀerences in
walking between visit 1 and 2.
All gait parameters on the walking trajectory under single
and dual task walking with regard to test retest reliability
are illustrated in Figure 2 by Bland-Altman plots. The results
of the test retest reliabilities are summarized in Table 3.
The reliability of single task walking speed, cadence, step
duration, and step length was “excellent” [32] (ICCs between
0.824–0.898 and SEMs between 0.03–5.2) and comparable
to the reliability of dual task walking speed, cadence, step
duration and step length (ICCs between 0.826–0.869 and
SEMs between 0.1–5.38).
4.3. Validity. The mean values and standard deviations of
the gait parameters of 29 evaluated patients at baseline are
reported in Table 4 for their grouping. Planned contrasts
showed that there was no significant eﬀect on SDu, V,
and cadence and a significant eﬀect of grouping on step
length performance. This latter parameter, however, showed
a large eﬀect [38]. The planned contrasts revealed that having
mild and severe PN did not significantly alter step length
compared to diabetic patients presenting without PN, t(26)
= −1.318, P = .101, and having severe PN significantly
influenced step length compared to mild PN, t(26) =−2.469,
P = .046 (one tailed).
5. Discussion
This study has shown that the reliability of walking speed,
cadence, step duration and step length on diﬀerent surfaces
and under dual task conditions was high with excellent ICCs,
small SEMs and RLOAs in older adults with diabetes using
the DynaPort MiniMod system. Results from discriminant
validity were essentially non conclusive, with the exception
of step length. There are, therefore, only indications that the
system might also be able to distinguish between subpopu-
lations within the population of patients with diabetes based
on step length. The disease status of the elderly participants
in our study varied from having diabetes without PN and
having diabetes with mild or severe polyneuropathy. We
thus expected our subjects to represent a heterogeneous
group with regard to walking abilities. From previous studies
we know that disease severity negatively influences walking
velocity [4] especially in challenging environments where
patients with neuropathy walk slower when compared to
patients without neuropathy [12]. We think that the negative
findings in our cross-sectional sample are very likely related
to the limited statistical power of this analysis and might
be attributed to a possible Type I error. A post hoc power
analysis revealed that Power (1-β err prob) = 0.19. Our data
allow for an a priori sample size calculation for a future trial
with a fixed eﬀects one-way ANOVA design and under the
assumption of a moderate eﬀect size of 0.25. To avoid a type
I or II error in this future trial, we need an estimated sample
size of 159 (53 individuals per group). This would result in
80% power at α-level 0.05 [39].
The gait changes that we observed in dual task walking
relative to single task walking are consistent with other stud-
ies that demonstrate that cognitive tasks have a destabilizing
eﬀect on gait [40–44]. This finding seems to indicate that
it is important to consider additional cognitive tasks in
gait assessment of diabetic patient populations in clinical
practice.
There is scarce information available about the reliability
of body fixed sensor approaches to assess gait parameters
in older adults with diabetes. The ICCs for walking speed
and cadence that we found were, however, similar to values
reported by Allet et al. [19] who were using the Physilog
system in older, diabetic subjects.
The relative reliability is the degree to which individuals
maintain their test results in a sample with repeatedmeasure-
ments and is aﬀected by sample heterogeneity, that means
the more heterogeneous a sample is, the higher the relative
reliability becomes. Therefore, a high correlation may still
mean unacceptable measurement error for some analytical
goals, for example, for individualised assessments [36], and
data about absolute reliabilities of a test are desired for
clinical use. The determination of what constitutes an accept-
able RLOA depends on what size diﬀerence the researcher
6 Journal of Aging Research
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Figure 2: Continued.
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Figure 2: Bland-Altman plots of (a) step duration, (b) step length, (c) walking velocity, and (d) cadence (top to bottom). Left side represents
the single task condition, and the right side represents the dual task walking.
Table 3: Reliability of diﬀerent gait parametersa at preferred speed (ICC: intraclass correlation coeﬃcient, CI 95% confidence interval 95%,
SEM standard error of measurement, SDD smallest detectable diﬀerence, and LALB limits of agreement lower boundary, LAUB limits of
agreement upper boundary).
ICC CI 95% SEM CI 95% SDD LALB LAUB
Single task
SDu (s) 0.848 0.652–0.933 0.03 ±0.06 0.09 −0.072 0.071
SL (m) 0.898 0.767–0.955 0.04 ±0.09 0.12 −0.128 0.124
V (m/s) 0.824 0.597–0.923 0.12 ±0.25 0.35 −0.349 0.354
Cad (step/min) 0.834 0.623–0.927 5.20 ±10.2 14.42 −13.754 15.096
Dual task
SDu (s) 0.829 0.597–0.926 0.10 ±0.20 0.28 −0.077 0.119
SL (m) 0.869 0.706–0.942 0.17 ±0.34 0.48 −0.159 0.130
V (m/s) 0.829 0.616–0.924 0.13 ±0.26 0.37 −0.431 0.318
Cad (step/min) 0.826 0.672–0.940 5.38 ±10.54 14.90 −18.101 14.901
SDu: step duration; SL: step length; V : velocity; Cad: cadence.
aCalculations—SEM:
√
Mean square error; CI 95% = ±1.96 × SEM; SDD = 1.96 ×√2× SEM.
Table 4: The mean and standard deviations of the gait parameters of 29 evaluated patients, grouped based on disease status, at baseline.
Performance measure
Group
Diabetic (n = 12) Mild neuropathy (n = 11) Severe neuropathy (n = 6)
Single task
Step duration (SDu; s) 0.56± 0.03 0.53± 0.05 0.55± 0.05
Step length (SL; m) 0.72± 0.06 0.73± 0.1 0.62± 0.12
Velocity (m·s−1) 1.29± 0.14 1.39± 0.14 1.14± 0.37
Cadence (steps/min) 107± 5.8 115± 10.2 107.6± 15
Dual task
Step duration (SDu; s) 0.6± 0.08 0.55± 0.05 0.6± 0.12
Step length (SL; m) 0.7± 0.07 0.7± 0.13 0.63± 0.1
Velocity (m·s−1) 1.18± 0.21 1.31± 0.28 1.09± 0.32
Cadence (steps/min) 101.4± 11 110± 9.3 103.4± 17.6
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or clinician wants to detect when comparing groups or
when assessing the eﬀect of interventions [45]. Whether
the absolute reliability reported here for the gait measures
is suﬃciently high to identify gait impairments or small
eﬀects of an intervention program to improve walking in
populations suﬀering from diabetes should be part of future
studies. In particular, the RLOAs for step length and gait
velocity might be indicative for rather large needed changes
to be detected with the system. A study that investigated
gait recovery in a sample of patients with diabetes due to
specific exercises [46], with a mean age of 63 years and
that used the Physilog gait analysis system for evaluation
in challenging environments, showed that changes in gait
velocity of around 0.149m·s−1, and improvements of 10%
for cadence are achievable with specific rehabilitation [5, 6].
Whether such changes are also clinically meaningful should
be determined in future studies.
In the present study we have shown that step length mea-
sures derived from the DynaPort MiniMod are significantly
diﬀerent between groups of patients. There are measurable
diﬀerences between individuals with mild and severe PN.
Clinical detection of these diﬀerences potentially allows the
division of diabetes patients into two groups with diﬀerent
mean step length: one with severe NP and one without
severe NP. These results support the assertion that there is
a relationship between quality of walking and the presence of
PN. However, these are only preliminary data, and further
(cross-sectional and longitudinal) research is needed with
larger samples to substantiate this observation.
To obtain the diagnostic information from a walking test
in a challenging environment alone, the outcomes of the gait
analysis should be compared with other diagnostic tests in
use. This necessitates the concurrent measurement of those
tests in future research. Therefore, bigger samples of subjects
should be selected in the future, and with logistic regression
analysis the contribution of the DynaPort MiniMod gait
assessment to existing diagnostic tests should be estimated
more precisely [47].
6. Conclusions
The results of this study demonstrate that walking speed,
cadence, step duration, and step length under more chal-
lenging conditions can be reliably measured in adults with
diabetes using the DynaPort MiniMod system. There are first
indications that the system is able to discriminate subgroups
of patients with diabetes based on their step length. Further
research in diabetic populations is needed to determine
the value of these parameters that are derived from this
measurement system in clinical settings.
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